Anhui Fengyuan Pharmaceutical Co Ltd

SHE:000153 China Drug Manufacturers - Specialty & Generic
Market Cap
$416.73 Million
CN¥3.06 Billion CNY
Market Cap Rank
#12501 Global
#3099 in China
Share Price
CN¥6.58
Change (1 day)
-1.64%
52-Week Range
CN¥5.58 - CN¥7.61
All Time High
CN¥22.93
About

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.

Anhui Fengyuan Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of December 2022: 1.81%

Anhui Fengyuan Pharmaceutical Co Ltd (000153) has an Asset Resilience Ratio of 1.81% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥80.69 Million
Cash + Short-term Investments
Total Assets
CN¥4.47 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2020)

This chart shows how Anhui Fengyuan Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Anhui Fengyuan Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥80.69 Million 1.81%
Total Liquid Assets CN¥80.69 Million 1.81%

Asset Resilience Insights

  • Limited Liquidity: Anhui Fengyuan Pharmaceutical Co Ltd maintains only 1.81% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Anhui Fengyuan Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Anhui Fengyuan Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%
Ildong Holdings Co Ltd
KO:000230
Drug Manufacturers - Specialty & Generic 1.57%

Annual Asset Resilience Ratio for Anhui Fengyuan Pharmaceutical Co Ltd (2016–2020)

The table below shows the annual Asset Resilience Ratio data for Anhui Fengyuan Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2020-12-31 0.19% CN¥6.99 Million CN¥3.64 Billion -0.09pp
2019-12-31 0.28% CN¥9.87 Million CN¥3.56 Billion +0.02pp
2018-12-31 0.26% CN¥7.79 Million CN¥3.01 Billion -0.23pp
2017-12-31 0.49% CN¥13.47 Million CN¥2.77 Billion -0.32pp
2016-12-31 0.81% CN¥20.06 Million CN¥2.49 Billion --
pp = percentage points